start portlet menu bar end portlet menu bar

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Home Knowledge Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

The aim of this study was to assess the efficacy of a two shots M. hyo vaccine in a commercial pig farm in China, where two different vaccination protocols were used. 

Download this article

932 KB

About this article

Appeared in

IPVS Congress China, 2018

Date

Jul 13, 2018

Authors

Huibo, N.; Guochun, W.; Wenyuan X.; Ming, H.W.; Martínez, C.

Summary

This study shows that the recomended program of a double dose of MYPRAVAC® SUIS compared with the single dose protocol exhibits better growth performace, higher survival rate, better average daily gain and a lower Feed Conversion Ratio.

Related products

MYPRAVAC® SUIS

Related publications

Mycoplasma hyopneumoniae vaccine in finishing pigs Mycoplasma hyopneumoniae infection dynamics in a farm Longitudinal study of Mycoplasma hyopneumoniae

Share this on

start portlet menu bar

Effect of a mycoplasma hyopneumoniae vaccine on growth performance in swine

Display portlet menu
end portlet menu bar

See also

Publications

Intradermal application of vaccines in pigs (Poster)

04-10-2018
Disease Summaries

Edema disease

03-11-2017
News

HIPRA takes a step forward in Taiwan with the launch of UNISTRAIN® PRRS vaccine

11-10-2018